Manufacture process of N-substituted salicylamides

Details for Australian Patent Application No. 2005315850 (hide)

Owner Novartis AG

Inventors Meier, Ulrich; Riss, Bernhard

Agent Davies Collison Cave

Pub. Number AU-B-2005315850

PCT Pub. Number WO2006/063821

Priority 0427603.6 16.12.04 GB

Filing date 14 December 2005

Wipo publication date 22 June 2006

Acceptance publication date 5 November 2009

International Classifications

C07C 235/60 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms

A61K 47/18 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

C07C 231/08 (2006.01) Preparation of carboxylic acid amides

C07C 233/24 (2006.01) Carboxylic acid amides

C07C 235/58 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms

C07D 265/26 (2006.01) Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms

Event Publications

7 June 2007 PCT application entered the National Phase

  PCT publication WO2006/063821 Priority application(s): WO2006/063821

5 November 2009 Application Accepted

  Published as AU-B-2005315850

4 March 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005315855-Combination therapy comprising telmisartan and hydrochlorothiazide

2005315849-Pyrazolo-heteroaryl compounds useful to treat TNF-Alpha and IL-1 mediated diseases